Form 4 for OGN Organon & Co.
Accepted 2024-09-05 00:00:00 ET · period of report 2024-09-03 · accession 0001821825-24-000098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-05 | 2024-09-03 | OGN | WALSH MATTHEW M | CFO | F - Tax | $20.35 | -3,541 | 92.0K | -4% | -$72.1K | |
| 2024-09-05 | 2024-09-03 | OGN | WALSH MATTHEW M | CFO | A - Grant | $0.00 | +7,189 | 95.5K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-03 | F | D | 3,541 | $20.35 | 91,974 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-03 | A | A | 7,189 | $0.00 | 95,515 | D | — | — | (F1) Represents shares of Organon & Co. common stock for performance share units granted to the reporting person on August 17, 2021 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors. |